3.2. MAP4K4 Is a Prognostic Biomarker Only in MSI-GC and Not in Other GC Molecular Subtypes, Identifying a Very Adverse Group in MSI with the CIN-like Phenotype. Here, MAP4K4 is linked to gastric cancer.